CGRP was shown to alleviate lung injury, inflammation, oxidative stress, and apoptosis in LPS-induced ARDS through the CGRP receptor (RAMP1), inhibit the classical activation of macrophages, and promote the alternative activation of macrophages. Here, CALCA is linked to acute respiratory distress syndrome.